Cargando…

TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains

BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease s...

Descripción completa

Detalles Bibliográficos
Autores principales: Estades Ayuso, Virginia, Pickles, Sarah, Todd, Tiffany, Yue, Mei, Jansen-West, Karen, Song, Yuping, González Bejarano, Jesús, Rawlinson, Bailey, DeTure, Michael, Graff-Radford, Neill R., Boeve, Bradley F., Knopman, David S., Petersen, Ronald C., Dickson, Dennis W., Josephs, Keith A., Petrucelli, Leonard, Prudencio, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441763/
https://www.ncbi.nlm.nih.gov/pubmed/37605276
http://dx.doi.org/10.1186/s13024-023-00646-z
_version_ 1785093444166746112
author Estades Ayuso, Virginia
Pickles, Sarah
Todd, Tiffany
Yue, Mei
Jansen-West, Karen
Song, Yuping
González Bejarano, Jesús
Rawlinson, Bailey
DeTure, Michael
Graff-Radford, Neill R.
Boeve, Bradley F.
Knopman, David S.
Petersen, Ronald C.
Dickson, Dennis W.
Josephs, Keith A.
Petrucelli, Leonard
Prudencio, Mercedes
author_facet Estades Ayuso, Virginia
Pickles, Sarah
Todd, Tiffany
Yue, Mei
Jansen-West, Karen
Song, Yuping
González Bejarano, Jesús
Rawlinson, Bailey
DeTure, Michael
Graff-Radford, Neill R.
Boeve, Bradley F.
Knopman, David S.
Petersen, Ronald C.
Dickson, Dennis W.
Josephs, Keith A.
Petrucelli, Leonard
Prudencio, Mercedes
author_sort Estades Ayuso, Virginia
collection PubMed
description BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease severity compared to AD patients without TDP-43 pathology. However, it remains unclear to what extent TDP-43 dysfunction is involved in AD pathogenesis. METHODS: To investigate whether TDP-43 dysfunction is a prominent feature in AD-TDP cases, we evaluated whether non-conserved cryptic exons, which serve as a marker of TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), accumulate in AD-TDP brains. We assessed a cohort of 192 post-mortem brains from three different brain regions: amygdala, hippocampus, and frontal cortex. Following RNA and protein extraction, qRT-PCR and immunoassays were performed to quantify the accumulation of cryptic RNA targets and phosphorylated TDP-43 pathology, respectively. RESULTS: We detected the accumulation of misspliced cryptic or skiptic RNAs of STMN2, KCNQ2, UNC13A, CAMK2B, and SYT7 in the amygdala and hippocampus of AD-TDP cases. The topographic distribution of cryptic RNA accumulation mimicked that of phosphorylated TDP-43, regardless of TDP-43 subtype classification. Further, cryptic RNAs efficiently discriminated AD-TDP cases from controls. CONCLUSIONS: Overall, our results indicate that cryptic RNAs may represent an intriguing new therapeutic and diagnostic target in AD, and that methods aimed at detecting and measuring these species in patient biofluids could be used as a reliable tool to assess TDP-43 pathology in AD. Our work also raises the possibility that TDP-43 dysfunction and related changes in cryptic splicing could represent a common molecular mechanism shared between AD-TDP and FTLD-TDP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00646-z.
format Online
Article
Text
id pubmed-10441763
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104417632023-08-22 TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains Estades Ayuso, Virginia Pickles, Sarah Todd, Tiffany Yue, Mei Jansen-West, Karen Song, Yuping González Bejarano, Jesús Rawlinson, Bailey DeTure, Michael Graff-Radford, Neill R. Boeve, Bradley F. Knopman, David S. Petersen, Ronald C. Dickson, Dennis W. Josephs, Keith A. Petrucelli, Leonard Prudencio, Mercedes Mol Neurodegener Research Article BACKGROUND: Inclusions of TAR DNA-binding protein 43 kDa (TDP-43) has been designated limbic-predominant, age-related TDP-43 encephalopathy (LATE), with or without co-occurrence of Alzheimer’s disease (AD). Approximately, 30–70% AD cases present TDP-43 proteinopathy (AD-TDP), and a greater disease severity compared to AD patients without TDP-43 pathology. However, it remains unclear to what extent TDP-43 dysfunction is involved in AD pathogenesis. METHODS: To investigate whether TDP-43 dysfunction is a prominent feature in AD-TDP cases, we evaluated whether non-conserved cryptic exons, which serve as a marker of TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), accumulate in AD-TDP brains. We assessed a cohort of 192 post-mortem brains from three different brain regions: amygdala, hippocampus, and frontal cortex. Following RNA and protein extraction, qRT-PCR and immunoassays were performed to quantify the accumulation of cryptic RNA targets and phosphorylated TDP-43 pathology, respectively. RESULTS: We detected the accumulation of misspliced cryptic or skiptic RNAs of STMN2, KCNQ2, UNC13A, CAMK2B, and SYT7 in the amygdala and hippocampus of AD-TDP cases. The topographic distribution of cryptic RNA accumulation mimicked that of phosphorylated TDP-43, regardless of TDP-43 subtype classification. Further, cryptic RNAs efficiently discriminated AD-TDP cases from controls. CONCLUSIONS: Overall, our results indicate that cryptic RNAs may represent an intriguing new therapeutic and diagnostic target in AD, and that methods aimed at detecting and measuring these species in patient biofluids could be used as a reliable tool to assess TDP-43 pathology in AD. Our work also raises the possibility that TDP-43 dysfunction and related changes in cryptic splicing could represent a common molecular mechanism shared between AD-TDP and FTLD-TDP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13024-023-00646-z. BioMed Central 2023-08-21 /pmc/articles/PMC10441763/ /pubmed/37605276 http://dx.doi.org/10.1186/s13024-023-00646-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Estades Ayuso, Virginia
Pickles, Sarah
Todd, Tiffany
Yue, Mei
Jansen-West, Karen
Song, Yuping
González Bejarano, Jesús
Rawlinson, Bailey
DeTure, Michael
Graff-Radford, Neill R.
Boeve, Bradley F.
Knopman, David S.
Petersen, Ronald C.
Dickson, Dennis W.
Josephs, Keith A.
Petrucelli, Leonard
Prudencio, Mercedes
TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title_full TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title_fullStr TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title_full_unstemmed TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title_short TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
title_sort tdp-43-regulated cryptic rnas accumulate in alzheimer’s disease brains
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441763/
https://www.ncbi.nlm.nih.gov/pubmed/37605276
http://dx.doi.org/10.1186/s13024-023-00646-z
work_keys_str_mv AT estadesayusovirginia tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT picklessarah tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT toddtiffany tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT yuemei tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT jansenwestkaren tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT songyuping tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT gonzalezbejaranojesus tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT rawlinsonbailey tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT deturemichael tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT graffradfordneillr tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT boevebradleyf tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT knopmandavids tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT petersenronaldc tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT dicksondennisw tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT josephskeitha tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT petrucellileonard tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains
AT prudenciomercedes tdp43regulatedcrypticrnasaccumulateinalzheimersdiseasebrains